A European clinical trial found that the drug sulthiame significantly reduced breathing interruptions in people with moderate to severe sleep apnea. Patients taking higher doses experienced up to 47% fewer pauses in breathing and improved oxygen levels during sleep. The drug helps stabilize breathing signals in the brain, reducing airway collapse. Scientists say the findings could pave the way for a pill-based alternative to CPAP machines.
View the full article